The European Patent Office Allows Patent for RESP3000
Respiratorius announces that the European Patent Office – EPO has issued a Decision to Grant a patent application for RESP3000 series, designed for use in cardiovascular diagnostics with PET-camera. Since earlier patents for RESP3000 are issued in the United States, Japan, Israel, Australia, South Africa, and Russia. In addition, a divisional application for RESP3000 on specific product requirements was recently approved in the US during 2017.The substances in the RESP3000 series specifically binds to mitochondria, and since the heart muscle is rich in mitochondria allowing for high